Clinical Trial Update: Study on Cognitive Disorders of Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on cognitive disorders associated with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University Hospital, Caen | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED